人类遗传学解析缺血性卒中结局机制:从早期脑损伤到长期康复
本文探讨反向转化方法,以补充传统正向转化方法,识别与人类缺血性卒中结局相关的机制。全文围绕缺血性卒中结局的遗传学研究展开,讨论结局表型设计、已有全基因组关联研究(GWAS)的发现及多组学等新技术在揭示药物靶点方面的前景。
要点
- 缺血性卒中结局的遗传学研究需使用锚定发病时间的标准化表型。
- 针对卒中结局的GWAS数量有限,需更大规模研究解析其遗传结构。
- 多组学与新型分析技术有望识别药物靶点及新干预措施。
核心结论
- 需要更大规模、采用标准化表型的研究来理解缺血性卒中结局的遗传结构。
- GWAS之外的新技术有望揭示可用于识别药物靶点和新干预措施的遗传与分子通路。
研究设计与样本
- 综述类:探讨反向转化方法,以补充传统正向转化方法识别与人类卒中结局相关的机制。
主要发现
- GWAS已发现超过30个影响缺血性卒中风险的遗传位点,但针对卒中结局的GWAS仅开展了少数几项。
- 有多项正在进行的计划在探索与卒中结局相关的新表型的基因组关联。
临床怎么用
- 卒中结局遗传研究应精心设计能反映损伤/康复机制、并锚定卒中发病时间的表型。
- 优先将标准化表型嵌入标准诊疗措施中,以支持大规模研究。
局限性
- 针对缺血性卒中结局的GWAS数量有限,现有证据尚不足以充分阐明其遗传结构。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
There is a critical need to elucidate molecular mechanisms underlying brain injury, repair, and recovery following ischemic stroke-a global health problem with major social and economic impact. Despite 5 decades of intensive research, there are no widely accepted neuroprotective drugs that mitigate ischemic brain injury, or neuroreparative drugs, or personalized approaches that guide therapies to enhance recovery. We here explore novel reverse translational approaches that will complement traditional forward translational methods in identifying mechanisms relevant to human stroke outcome. Although genome-wide association studies have yielded over 30 genetic loci that influence ischemic stroke risk, only a few genome-wide association studies have been performed for stroke outcome. We discuss important considerations for genetic studies of ischemic stroke outcome-including carefully designed phenotypes that capture injury/recovery mechanisms, anchored in time to stroke onset. We also address recent genome-wide association studies that provide insight into mechanisms underlying brain injury and repair. There are several ongoing initiatives exploring genomic associations with novel phenotypes related to stroke outcome. To improve the understanding of the genetic architecture of ischemic stroke outcome, larger studies using standardized phenotypes, preferably embedded in standard-of-care measures, are needed. Novel techniques beyond genome-wide association studies-including exploiting informatics, multi-omics, and novel analytics-promise to uncover genetic and molecular pathways from which drug targets and other new interventions may be identified.
引用
- Lee JM, Fernandez-Cadenas I, Lindgren AG, et al. Using Human Genetics to Understand Mechanisms in Ischemic Stroke Outcome: From Early Brain Injury to Long-Term Recovery. Stroke. 2021. PMID: 34399587. doi:10.1161/STROKEAHA.121.032622
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。